Cargando…
Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2018
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548234/ https://www.ncbi.nlm.nih.gov/pubmed/31986533 http://dx.doi.org/10.1055/s-0039-3400530 |
| _version_ | 1784590528742948864 |
|---|---|
| author | Weycker, Derek Li, Xiaoyan Wygant, Gail DeVecchis Lee, Theodore Hamilton, Melissa Luo, Xuemei Vo, Lien Mardekian, Jack Pan, Xianying Burns, Leah Atwood, Mark Hanau, Ahuva Cohen, Alexander T. |
| author_facet | Weycker, Derek Li, Xiaoyan Wygant, Gail DeVecchis Lee, Theodore Hamilton, Melissa Luo, Xuemei Vo, Lien Mardekian, Jack Pan, Xianying Burns, Leah Atwood, Mark Hanau, Ahuva Cohen, Alexander T. |
| author_sort | Weycker, Derek |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8548234 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Georg Thieme Verlag KG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85482342021-10-28 Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice Weycker, Derek Li, Xiaoyan Wygant, Gail DeVecchis Lee, Theodore Hamilton, Melissa Luo, Xuemei Vo, Lien Mardekian, Jack Pan, Xianying Burns, Leah Atwood, Mark Hanau, Ahuva Cohen, Alexander T. Thromb Haemost Georg Thieme Verlag KG 2018-11 2020-01-27 /pmc/articles/PMC8548234/ /pubmed/31986533 http://dx.doi.org/10.1055/s-0039-3400530 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
| spellingShingle | Weycker, Derek Li, Xiaoyan Wygant, Gail DeVecchis Lee, Theodore Hamilton, Melissa Luo, Xuemei Vo, Lien Mardekian, Jack Pan, Xianying Burns, Leah Atwood, Mark Hanau, Ahuva Cohen, Alexander T. Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice |
| title | Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice |
| title_full | Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice |
| title_fullStr | Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice |
| title_full_unstemmed | Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice |
| title_short | Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice |
| title_sort | erratum: effectiveness and safety of apixaban versus warfarin as outpatient treatment of venous thromboembolism in u.s. clinical practice |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548234/ https://www.ncbi.nlm.nih.gov/pubmed/31986533 http://dx.doi.org/10.1055/s-0039-3400530 |
| work_keys_str_mv | AT weyckerderek erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT lixiaoyan erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT wygantgaildevecchis erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT leetheodore erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT hamiltonmelissa erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT luoxuemei erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT volien erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT mardekianjack erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT panxianying erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT burnsleah erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT atwoodmark erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT hanauahuva erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice AT cohenalexandert erratumeffectivenessandsafetyofapixabanversuswarfarinasoutpatienttreatmentofvenousthromboembolisminusclinicalpractice |